Salem Investment Counselors’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
JMFC
QFMHK
BSWM
TWM
FIA
EP
FFO
Salem Investment Counselors's DNA Position: Q3 2026 in Review
Salem Investment Counselors sold out of Ginkgo Bioworks (DNA) in Q3 2026, closing a stake of 591 shares — an estimated $5.86K sold.
Salem Investment Counselors first reported a position in DNA in Q2 2022 and held it in 16 quarters. The position peaked at $5.52M in Q1 2024. 15 funds tracked by Wall St. Rank hold DNA as of Q3 2026.
- Salem Investment Counselors reported no remaining Ginkgo Bioworks position as of Q3 2026 after selling out during the quarter.
- Salem Investment Counselors sold 591 Ginkgo Bioworks shares in Q3 2026, an estimated $5.86K.
- Salem Investment Counselors first reported a position in Ginkgo Bioworks in Q2 2022 and held it in 16 quarters.
- Salem Investment Counselors's Ginkgo Bioworks position peaked at $5.52M in Q1 2024.
- 15 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.
Based on Salem Investment Counselors's 13F filing for Q3 2026, filed 13 Oct 2026.